Understanding Your ROI

John Elliott from Carevive delves into the pressing question of ROI in the evolving landscape of value-based care reimbursement models. As the oncology care model (OCM) transitions into the enhancing oncology model, stakeholders are evaluating the technology, processes, and resources that will support their future endeavors.

Carevive proves to be a twofold solution, seamlessly aligning with the current fee-for-service model for chronic care management. By providing tools and solutions to manage symptoms, Carevive aids in avoiding hospitalizations and enhancing patient outcomes, leading to additional revenue and reimbursements for partners.

Moreover, Carevive is firmly positioned to align with the future enhanced oncology model, as it focuses on driving transformation, quality metrics, and health equity advancement. The integration of electronic patient-reported outcomes (ePROs) exemplifies Carevive’s commitment to symptom remote management, a vital component of the future model.

Recent Episodes

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Healthcare systems are entering 2026 under mounting pressure. A growing, aging population and rising disease burden are colliding with persistent workforce shortages—highlighted by projections that new cancer diagnoses in the U.S. will surpass two million this year alone. The stakes are no longer theoretical: delays in care, limited specialist access, and widening disparities are…